Success Stories: EB-2 NIW Approval for Scientist Advancing Pediatric Cancer Research

Posted by wegreened on January 30, 2026 in NIW, Protein Science

Client’s Testimonial:

“Thank you for the message. Yes, it was great working with you. The attorney was excellent so far. I am happy with the service provided.”

On August 21^st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Student in the Field of Physics (Approval Notice).

General Field: Protein Science

Position at the Time of Case Filing: Scientist

Country of Origin: India

State of Residence at the Time of Filing: Tennessee

Approval Notice Date: August 21^st, 2025

Processing Time: 5 months, 16 days (Premium Processing Requested)

Case Summary:

NAILG is proud to share another EB-2 NIW (National Interest Waiver) success, this time for a scientist from India specializing in protein science. The petition was filed on March 5, 2025, and, after a request for evidence issued on April 17, it was approved on August 21, 2025, with the help of premium processing.

Pioneering Research in Protein Science

The client’s work is centered on uncovering molecular mechanisms and signaling pathways in pediatric cancers. His goal is to identify therapeutic targets and develop targeted treatments that reduce healthcare burdens while improving survival outcomes. This line of research not only addresses a pressing medical challenge in the United States but also contributes to broader global health needs.

Accomplishments and Scholarly Recognition

Publications: 13 peer-reviewed journal articles and 1 first-authored abstract in leading journals of biochemistry, protein science, and structural biology.
Citations: His work has accrued 193 citations, with three papers ranking among the top 20% most cited in their respective years.
Peer Reviews: Completed at least 12 reviews for respected journals in molecular biosciences and protein chemistry.
Editorial Service: Invited to serve on an editorial board and as guest editor of a special issue, roles that reflect his standing in the scientific community.
Funding: His research has benefited from national and institutional support, including projects tied to cancer biology and drug development.

These credentials positioned him as a recognized authority in protein science and underscored his ability to continue advancing this endeavor.

Why USCIS Approved the Petition

In our legal strategy, NAILG demonstrated that:

His research has substantial merit and national importance, tackling one of the leading causes of childhood mortality in the U.S.
He is well-positioned to advance the endeavor, evidenced by his publication record, citation impact, peer review service, and editorial leadership.
On balance, granting a waiver of the labor certification requirement is clearly beneficial to the United States, as his expertise directly supports progress in cancer treatment and biomedical innovation.

NIW Approval and Outlook

With this approval, the client is poised to continue driving forward protein science innovations that can transform the treatment of pediatric cancers. At NAILG, we are honored to have supported his journey and look forward to his future contributions to public health and biomedical research in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%